Research articleApigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT☆
Introduction
Colorectal cancer (CRC) is a major cause of morbidity and mortality in the United States (US). The estimated new cases of CRC in 2012 are 143 460, and the estimated deaths are 51 690, both accounting for 9% among the total ten leading cancers of US. It affects men and women equally and is the third leading cause of death [1]. The incidence and mortality of CRC is rising rapidly in Asia [2], and it is one of the three cancers with the greatest increasing incidence in China between 1991 and 2005 [3]. The incidence and mortality rates of CRC increased by 38.56% and 15.30% from 1988 to 2002 in 10 cities and counties in China [4]. Thus, measurements for the prevention and treatment of CRC in the whole population are of long run significance in future.
Although about 50% of the tumours can be curatively treated by surgery alone, metastatic growth is one of the major factors that compromised the outcome of cancer treatment, which is particularly true for the high mortality rate of CRC [5], [6]. Approximately half of CRC patients will develop local recurrence or distant metastasis during the course of the illness [7]. Although lymph node metastasis represents the primary indicator for systemic disease spread, distant metastases formation constitutes the most important prognostic factor in colorectal cancer and accounts for the majority of deaths [5]. Therefore the prevention of CRC metastasis, especially distant metastasis, becomes more important.
Apigenin is a flavonoid that widely existed in fruits and vegetables. It structurally belongs to the flavone class and is chemically known as 4′,5,7,-trihydroxyflavone. It has been found to possess various clinically relevant properties such as anti-tumour, anti-platelet and anti-inflammatory activities [8], [9]. It has also been reported to suppress tumour metastasis in an orthotopic ovarian tumour model [10] and to inhibit hepatocyte growth factor promoted lung metastasis [11]. Apigenin significantly decreased the incidence of peritoneal metastasis of azoxymethane and bombesin induced intestinal adenocarcinomas [12]. Our previous work showed that apigenin inhibited the growth of colorectal cancer xenografts [13]. However, whether apigenin could decrease the metastasis in an orthotopic CRC model is unknown.
The process of dissemination of CRC to discontiguous vicinity or distant secondary sites comprises several necessary steps: invasion, adhesion, migration and proliferation at the secondary site [14]. In the current study, the effects of apigenin on cell proliferation, migration and invasion were addressed. As many studies focused on phosphatidylinositol 3-kinases /Akt pathway [10], [11], a two-dimensional electrophoresis-based proteomic analysis was adopted to screen new target proteins of apigenin. The relationship between phosphatidylinositol 3-kinases/Akt and the new target proteins would be discussed further.
Section snippets
Chemicals
Apigenin, dimethyl sulfoxide (DMSO), propidium iodide (PI) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). RPMI 1640, FBS and antibiotics were purchased from Invitrogen (Gibco, Grand Island, NY, USA).
Animals and orthotopic CRC tumour model
All procedures involving laboratory animal use were in accordance with the guidelines of the Instituted Animal Care and Use Committee of Southern Medical University. All protocols were submitted and validated by Animal Care Ethics Committee of
Apigenin inhibits cell proliferation and invasion
Apigenin significantly decreased cell viability in a time and dose-dependent manner ranging from 20 to 120 μM. Cell viabilities decreased to 52.29%, 50.62% and 45.10% in SW480, DLD-1 and LS174T cells when treated with 40 μM apigenin for 48 h compared to the control (Fig. 1A). Therefore, apigenin 40 μM was chosen in the further study. A rat intestinal epithelial cell line (IEC-6) was also included in our study. Further analysis showed that the viabilities of SW480, DLD-1 and LS174T were higher
Discussion
Apigenin is a flavonoid structurally belonging to the flavone class and is found in traditional Chinese herbs such as Chrysanthemum morifolium Ramat [18] and tree peony flowers [19], etc. It has been reported that apigenin inhibited colon carcinoma cell growth via induction of G2/M arrest [20], [21]. Three kinds of colorectal adenocarcinoma cell lines including SW480-eGFP were utilized in this study for the convenience of fluorescence imaging of cell invasion and tumour metastasis. The
References (47)
- et al.
MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor[J]
Biochem Pharmacol
(2012) - et al.
Colorectal cancer liver metastasis: local treatment for a systemic disease?[J]
Ann Oncol
(1998) - et al.
Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells[J]
Toxicol Appl Pharmacol
(2008) - et al.
Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients[J]
Mod Pathol
(2009) - et al.
Chrysanthemum morifolium Ramat. reduces the oxidized LDL-induced expression of intercellular adhesion molecule-1 and E-selectin in human umbilical vein endothelial cells[J]
J Ethnopharmacol
(2010) - et al.
Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria[J]
Biochim Biophys Acta
(2011) - et al.
Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels[J]
J Biol Chem
(2011) - et al.
Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression[J]
J Biol Chem
(2006) - et al.
SM22alpha inhibits cell proliferation and protects against anticancer drugs and gamma-radiation in HepG2 cells: involvement of metallothioneins[J]
FEBS Lett
(2009) - et al.
Akt signalling in health and disease[J]
Cell Signal
(2011)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity[J]
Cell
In vivo imaging of tumor growth after electrochemotherapy with cisplatin[J]
Biochem Biophys Res Commun
Transgelin: an actin-binding protein and tumour suppressor[J]
Int J Biochem Cell Biol
Inhibition of HSP70: a challenging anti-cancer strategy[J]
Cancer Lett
Cancer statistics, 2012[J]
CA Cancer J Clin
Increased burden of colorectal cancer in Asia[J]
World J Gastrointest Oncol
Estimation and projection of the national profile of cancer mortality in China: 1991-2005[J]
Br J Cancer
Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002[J]
Zhonghua Zhong Liu Za Zhi
Clinical, biological, and molecular aspects of metastasis in colorectal cancer[J]
Recent Results Cancer Res
Apigenin and cancer chemoprevention: progress, potential and promise (review)[J]
Int J Oncol
Apigenin: a promising molecule for cancer prevention[J]
Pharm Res
Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model[J]
Int J Mol Sci
Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats[J]
Clin Exp Metastasis
Cited by (0)
- ☆
This work was supported by the National Science Foundation of China (No. 81273621), Planned Science Technology Project of Guangdong Province, China (No. 2011B031700001) and Baiyun District Science and Technology Program (No. 2012-KZ-81).
- 1
These authors contributed to this work equally.